# Neurodyn Life Sciences Inc.: Form D filings

Neurodyn Life Sciences Inc., a biotechnology company in Vancouver, British Columbia, Canada, filed 10 Form D notices with the SEC between 2013 and 2015. The latest, on November 2, 2015, reports $23,079 sold of a $23,079 offering to 1 investor.

Find out what Neurodyn Life Sciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Neurodyn%20Life%20Sciences%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Neurodyn%20Life%20Sciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurodyn-life-sciences-inc-1568852)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Neurodyn%20Life%20Sciences%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Neurodyn%20Life%20Sciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fneurodyn-life-sciences-inc-1568852)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 439 Helmcken Street, Vancouver, British Columbia, Canada, V6B 2
- Phone: (604) 684-3323
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: British Columbia, Canada
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1568852

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 2, 2015 | New notice | $23,079 | $23,079 | $0 | 1 | Oct 19, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036115039225/0001140361-15-039225-index.htm) |
| Oct 16, 2015 | New notice | $650,000 | $650,000 | $0 | 2 | Sep 30, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036115037869/0001140361-15-037869-index.htm) |
| Mar 11, 2015 | Amendment | $1,408,880 | $1,408,880 | $0 | 7 | Dec 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036115011311/0001140361-15-011311-index.htm) |
| Dec 8, 2014 | Amendment | $896,380 | $896,380 | $0 | 6 | Dec 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036114044465/0001140361-14-044465-index.htm) |
| Sep 25, 2014 | New notice | $349,185 | $349,185 | $0 | 1 | Jan 7, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036114036469/0001140361-14-036469-index.htm) |
| Sep 25, 2014 | New notice | $660,948 | $660,948 | $0 | 5 | Dec 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036114036467/0001140361-14-036467-index.htm) |
| Jun 12, 2013 | New notice | $100,280 | $100,280 | $0 | 1 | May 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036113024992/0001140361-13-024992-index.htm) |
| Apr 9, 2013 | New notice | $24,572 | $24,572 | $0 | 1 | Mar 30, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036113016020/0001140361-13-016020-index.htm) |
| Feb 6, 2013 | New notice | $125,874 | $125,874 | $0 | 1 | Nov 28, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036113004867/0001140361-13-004867-index.htm) |
| Feb 6, 2013 | New notice | $1,001,402 | $1,001,402 | $0 | 1 | Jan 23, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1568852/000114036113004839/0001140361-13-004839-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kenneth A. Cawkell | Executive Officer, Director |  |
| James L. Mertz | Director |  |
| Robert L. Cervelli | Director |  |
| Madolyn L. Mertz | Director |  |
| Richard L. Devries | Director |  |
| Denis G. Kay | Executive Officer, Director |  |

[Every Form D from the week of Nov 2, 2015](https://specstream.ai/data/form-d/week/2015-11-02) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Neurodyn Life Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).